Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05020951 · ClinicalTrials.gov registry record
Pilot Study to Enable Electronic Laboratory Data Transfer From Participating Institutions to MediData/RAVE
A clinical trial of Accurate and Complete Data Acquisition for Clinical Trials, sponsored by Children's Oncology Group.
- Active
- Registry status
- 118
- Enrollment target
- 8
- Study locations
NCT05020951: Active study of Accurate and Complete Data Acquisition for Clinical Trials, sponsored by Children's Oncology Group.
NCT05020951 is a study of Accurate and Complete Data Acquisition for Clinical Trials that is active but no longer recruiting, run by Children's Oncology Group. The registered enrollment target is 118 participants. The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05020951, a study of Accurate and Complete Data Acquisition for Clinical Trials, is active but no longer recruiting, sponsored by Children's Oncology Group.
- ACTIVE NOT RECRUITING
- Registry status
- 118 participants
- Enrollment target
- 8
- Study locations
Study Summary
An initial step toward more accurate and complete data acquisition for clinical trials, the Pediatric Early Phase Clinical Trials Network (PEP-CTN) and Pediatric Brain Tumor Consortium (PBTC) will assess the feasibility of electronic transfer of laboratory data from participating institutions' local electronic health records to the Medidata/RAVE that is housed within each consortium's Uniform Resource Locator (URL). This study will assess efficiency, effectiveness, and scalability of the laboratory data extraction and transfer processes. This study will identify factors in the process that impact consortium operations, central protocol activation and implementation to the point of declaring the site data-ready.
Conditions Studied
Interventions
- OTHER Medidata RAVE
Study Locations (8)
Georgia
- Children's Healthcare of Atlanta - Egleston - Atlanta
- Children's Healthcare of Atlanta - Atlanta
California
- UCSF Medical Center-Mission Bay - San Francisco
New York
- Memorial Sloan Kettering Cancer Center - New York
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Tennessee
- Saint Jude Children's Research Hospital - Memphis
Texas
- Texas Children's Hospital - Houston
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2021-08-28 |
| Est. Completion | 2026-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05020951
The ClinicalTrials.gov registry entry for NCT05020951 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Accurate and Complete Data Acquisition for Clinical Trials appearing as the primary indexed condition, and to 1 intervention - of which Medidata RAVE is the first listed.
NCT05020951 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Georgia, California, New York.
Frequently Asked Questions
What is clinical trial NCT05020951 about?
NCT05020951 is a clinical study titled "Pilot Study to Enable Electronic Laboratory Data Transfer From Participating Institutions to MediData/RAVE". An initial step toward more accurate and complete data acquisition for clinical trials, the Pediatric Early Phase Clinical Trials Network (PEP-CTN) and Pediatric Brain Tumor Consortium (PBTC) will assess the feasibility of electronic transfer of laboratory data from participating institutions' local...
What is the current status of trial NCT05020951?
This trial is currently active not recruiting. The enrollment target is 118 participants. The study started on 2021-08-28. Estimated completion is 2026-03-31.
What conditions does trial NCT05020951 study?
This clinical trial studies the following conditions: Accurate and Complete Data Acquisition for Clinical Trials.
What interventions are being tested in trial NCT05020951?
The interventions under investigation include: Medidata RAVE (OTHER).
Who is sponsoring clinical trial NCT05020951?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05020951 being conducted?
This trial has 8 study locations across California, Georgia, New York, Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.